Literature DB >> 10086977

Conduction disturbances and increased atrial vulnerability in Connexin40-deficient mice analyzed by transesophageal stimulation.

A Hagendorff1, B Schumacher, S Kirchhoff, B Lüderitz, K Willecke.   

Abstract

BACKGROUND: Recently, it has been reported that connexin40 (Cx40) deficiency in targeted mouse mutants is associated with a prolongation of P-wave and QRS complex duration on surface electrograms. The specific effects of Cx40 deficiency on sinus node function, sinoatrial, and atrioventricular conduction properties as well as on atrial vulnerability have not yet been investigated systematically by electrophysiological analysis. METHODS AND
RESULTS: Fifty-two mice (18 Cx40(+/+), 15 Cx40(+/-), and 19 Cx40(-/-) mice) were subjected to rapid atrial transesophageal stimulation after anesthesia with avertin. A significant prolongation of sinus node recovery time was noticed in Cx40(-/-) mice compared with Cx40(+/-) and Cx40(+/+) mice (287.8+/-109.0 vs 211.1+/-61.8 vs 204.4+/-60.9 ms; P<0.05). In addition, Wenckebach periodicity occurred at significantly longer atrial pacing cycle lengths in Cx40(-/-) mice than in Cx40(+/-) or Cx40(+/+) mice (93. 3+/-11.8 vs 83.9+/-9.7 vs 82.8+/-8.0 ms, P<0.05). Analysis of 27 Cx40(-/-) mice showed a significant increase in intra-atrial conduction time and atrioventricular conduction time compared with 52 Cx40(+/-) and 31 wild-type (Cx40(+/+)) mice. Furthermore, in Cx40(-/-) mice, atrial tachyarrhythmias could be induced frequently by atrial burst pacing, whereas no atrial arrhythmias were inducible in heterozygous or wild-type mice.
CONCLUSIONS: This study demonstrates that Cx40 deficiency is associated with sinoatrial, intra-atrial, and atrioventricular conduction disturbances. In atrial myocardium of the mouse, Cx40 deficiency results in increased atrial vulnerability and might contribute to arrhythmogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10086977     DOI: 10.1161/01.cir.99.11.1508

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  71 in total

1.  A role for calreticulin in the adult heart?

Authors:  A Maass; L A Leinwand
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

2.  Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies.

Authors:  Kenneth R Chien
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

3.  TBX5 drives Scn5a expression to regulate cardiac conduction system function.

Authors:  David E Arnolds; Fang Liu; John P Fahrenbach; Gene H Kim; Kurt J Schillinger; Scott Smemo; Elizabeth M McNally; Marcelo A Nobrega; Vickas V Patel; Ivan P Moskowitz
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

Review 4.  Atrial fibrillation: basic mechanisms, remodeling and triggers.

Authors:  Akiko Shiroshita-Takeshita; Bianca J J M Brundel; Stanley Nattel
Journal:  J Interv Card Electrophysiol       Date:  2005-09       Impact factor: 1.900

Review 5.  Dysregulation of cell adhesion proteins and cardiac arrhythmogenesis.

Authors:  Jifen Li; Vickas V Patel; Glenn L Radice
Journal:  Clin Med Res       Date:  2006-03

Review 6.  Connexin-mediated cardiac impulse propagation: connexin 30.2 slows atrioventricular conduction in mouse heart.

Authors:  Maria M Kreuzberg; Klaus Willecke; Feliksas F Bukauskas
Journal:  Trends Cardiovasc Med       Date:  2006-11       Impact factor: 6.677

7.  Investigation of connexin 43 uncoupling and prolongation of the cardiac QRS complex in preclinical and marketed drugs.

Authors:  M P Burnham; P M Sharpe; C Garner; R Hughes; C E Pollard; J Bowes
Journal:  Br J Pharmacol       Date:  2014-08-13       Impact factor: 8.739

8.  Fractal dynamics of heart beat interval fluctuations in corticotropin-releasing factor receptor subtype 2 deficient mice.

Authors:  Oliver Stiedl; Michael Meyer
Journal:  Integr Physiol Behav Sci       Date:  2002 Oct-Dec

9.  Systemic therapy in an RNA toxicity mouse model with an antisense oligonucleotide therapy targeting a non-CUG sequence within the DMPK 3'UTR RNA.

Authors:  Ramesh S Yadava; Qing Yu; Mahua Mandal; Frank Rigo; C Frank Bennett; Mani S Mahadevan
Journal:  Hum Mol Genet       Date:  2020-06-03       Impact factor: 6.150

10.  Immunomodulation by atorvastatin upregulates expression of gap junction proteins in coxsackievirus B3 (CVB3)-induced myocarditis.

Authors:  Alian Zhang; Huili Zhang; Shiyao Wu
Journal:  Inflamm Res       Date:  2009-09-23       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.